The therapeutic potential of ANXV is broad since its target phosphatidylserine (PS) is a factor in several diseases.
Annexin Pharmaceuticals investor pages.
Annexin is a biotechnology company in clinical stage and a leader in the Annexin A5 area. The company is listed at First North, Stockholm, and is headquartered in Stockholm, Sweden.
